Michael L. Meyers - Insider Trading & Ownership

Location
C/O Syndax Pharmaceuticals, Inc., 400 Totten Pond Road, Suite 110, Waltham, MA
Summary
The estimated net worth of Michael L. Meyers is at least $1.1M dollars as of June 20, 2025. Michael L. Meyers is the SVP, Chief Medical Officer of Syndax Pharmaceuticals Inc and owns shares of Syndax Pharmaceuticals Inc (SNDX) stock worth about $761K. Michael L. Meyers is the Director of Nuvalent, Inc. and owns shares of Nuvalent, Inc. (NUVL) stock worth about $343K.
Signature
/s/ Nathan N. McConarty, attorney-in-fact
All Insider Reports
All Insider Reports

Ownership of Michael L. Meyers

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SNDX Syndax Pharmaceuticals Inc SVP, Chief Medical Officer $761K Feb 2, 2022
NUVL Nuvalent, Inc. Director $343K Jun 18, 2025

Insider Transactions Reported by Michael L. Meyers:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.